Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 2, 1996, Pages 139-144

  Bhatnagar, D ^a   Durrington, P N ^a   Kumar, S ^a   Mackness, M I ^a   Boulton, A J M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

CETP, LCAT; Cholesteryl ester; Cholesteryl ester transfer; Lipoproteins; NIDDM

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRANSFERASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; ENZYME ACTIVITY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 2; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0029916607     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199602)13:2<139::AID-DIA15>3.0.CO;2-C     Document Type: Article

References (36)

1. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J 1983; 287: 867-870.
2. Stamler J, Vaccaro O, Neaton JD. Diabetes, other risk factors and 12 yr cardiovascular mortality for men screened in the multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
3. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-628.
4. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC. Cholesterol transport between cells and high density lipoproteins. Biochim Biophys Acta 1991; 1085: 273-298.
5. Glomset JA. The plasma lecithin:cholesterol acyl transferase reaction. J Lipid Res 1968; 9: 155-167.
6. Oram JF, Slotte JP. Aviram M, Duell PB, Graham DL, Bierman EL. High density lipoprotein receptor-mediated transport of excess cholesterol. In: NE Miller, ed. High Density Lipoproteins and Atherosclerosis II. Amsterdam: Elsevier Science Publishers, 1989: 255-232.
7. Swenson TL. Transfer proteins in reverse cholesterol transport. Curr Opinion Lipidol 1992; 3: 67-74.
8. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 47: 232.
9. Witzum JL. Role of oxidation of low density lipoproteins in atherogenesis. Br Heart J 1993; 69 (suppl 1): S12-S18.
10. Barter PJ. Enzymes involved in lipid and lipoprotein metabolism. Curr Opinion Lipidol 1990; 1: 518-523.
11. Maroti KP, Castle MK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 364: 73-75.
12. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, et al. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 1990; 323: 1234-1238.
13. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC. Accelerated cholesteryl ester transfer in non-insulin dependent diabetes mellitus. Atherosclerosis 1993; 104: 69-78.
14. Ahnadi CE, Masmoudi T, Berthezene F, Ponsin G. Decreased ability of high density lipoproteins to transfer cholesteryl esters in non-insulin dependent diabetes mellitus. Eur J Clin Invest 1993; 23: 459-465.
15. Trinder P, Webster D. Determination of HDL cholesterol using 2, 4, 6, -tribromo-3-hydroxybenzoic acid with commercial CHOD-PAP reagent. Ann Clin Biochem 1984; 21: 430-433.
16. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Gocke NM, Olson BJ, Klenk DC. Measurement of protein using bicinichoninic acid. Anal Biochem 1985; 150: 76-85.
17. Mackness MI, Durrington PN. Lipoprotein analysis for clinical studies. In: Converse CA, Skinner ER, eds. Lipoprotein Analysis: A Practical Approach. Oxford: Oxford University Press, 1991. pp 1-42.
18. Stokke KT, Norum KR. Determination of lecithin:cholesterol acyl transferase in human blood plasma. Scand J Clin Invest 1971; 27: 21-27.
19. Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 1990; 80: 217-276.
20. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolaemia. J Clin Invest 1991; 87: 1259-1265.
21. Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993; 98: 25-32.
22. Editorial. Cholesteryl ester transfer protein. Lancet 1991; 338: 666-667.
23. Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986; 27: 361-367.
24. Tall AR, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl esters in dyslipidaemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987; 79: 1217-1225.
25. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridaemia. J Clin Invest 1991; 88: 2059-2066.
26. Van Tol A. CETP-catalysed transfer of cholesteryl esters from HDL to apo B-containing lipoproteins in plasma from diabetic patients. Eur J Clin Invest 1993; 23: 856.
27. Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci 1984; 81: 2512-2516.
28. Morton RE. Interaction of lipid transfer protein with plasma lipoproteins and cell membranes. Experimentia 1990; 46: 552-560.
29. Bhatnagar D, Durrington PN, Mackness MI, Arrol S, Winocour PH, Prais H. Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins. Atherosclerosis 1992; 92: 49-57.
30. Vega GL, Beltz WF, Grundy SM. Low density lipoprotein metabolism in hypertriglyceridaemic and normolipidaemic patients with coronary artery disease. J Lipid Res 1985; 26: 115-126.
31. Tilly-Kiesi M, Syvanne M, Kuusi T, Lahdenpera S, Taskinen MR. Abnormalities in normolipidaemic type II diabetic and nondiabetic patients with coronary artery disease. J Lipid Res 1992; 33: 333-342.
32. Manzato E, Zambon A, Lapolla A, Zambon S, Braghetto L, Crepaldi G, Fedele D. Lipoprotein abnormalities in well-treated type II diabetic patients. Diab Care 1993; 16: 469-475.
33. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990; 10: 232-239.
34. Ishibasha S, Yamada N, Shimano H, Takaku F, Akanuma Y, Murase T. Composition of VLDL in non insulin dependent diabetes mellitus. Clin Chem 1989; 35: 808-812.
35. Lane JT, Subbaiah PV, Otto ME, Bagdade JD. Lipoprotein composition and HDL particle size distribution in women with non-insulin dependent diabetes mellitus and the effects of probucol treatment. J Lab Clin Med 1991; 118: 120-128.
36. Reaven GM. Resistance to insulin-stimulated glucose uptake and hyperinsulinaemia: role in non insulin dependent diabetes mellitus, high blood pressure, dyslipidaemia and coronary heart disease. Diabete Metab 1991; 17: 78-86.